Ion mobility-derived collision cross section as an additional measure for lipid fingerprinting and identification. by Paglia, Giuseppe et al.
UC San Diego
UC San Diego Previously Published Works
Title
Ion mobility-derived collision cross section as an additional measure for lipid fingerprinting and 
identification.
Permalink
https://escholarship.org/uc/item/5hh0c250
Journal
Analytical chemistry, 87(2)
ISSN
0003-2700
Authors
Paglia, Giuseppe
Angel, Peggi
Williams, Jonathan P
et al.
Publication Date
2015
DOI
10.1021/ac503715v
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
Ion Mobility-Derived Collision Cross Section As an Additional
Measure for Lipid Fingerprinting and Identification
Giuseppe Paglia,†,‡ Peggi Angel,§ Jonathan P. Williams,∥ Keith Richardson,∥ Hernando J. Olivos,∥
J. Will Thompson,⊥ Lochana Menikarachchi,# Steven Lai,∥ Callee Walsh,§ Arthur Moseley,⊥
Robert S. Plumb,∥,∇ David F. Grant,# Bernhard O. Palsson,∇ James Langridge,∥ Scott Geromanos,∥
and Giuseppe Astarita*,∥,○
†Istituto Zooprofilattico Sperimentale della Puglia e Della Basilicata, Foggia, Italy
‡Center for Systems Biology, University of Iceland, Reykjavik, Iceland
§Protea Biosciences Group, Inc., Morgantown, West Virginia 26505, United States
∥Waters Corporation, Milford, Massachusetts 01757, United States
⊥Duke Proteomics Core Facility, Durham, North Carolina 27708, United States
#Department of Pharmaceutical Sciences, University of Connecticut, Storrs, Connecticut 06268, United States
∇Computational and Systems Medicine, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London,
United Kingdom
○Department of Biochemistry and Molecular & Cellular Biology, Georgetown University, Washington, DC 20057, United States
*S Supporting Information
ABSTRACT: Despite recent advances in analytical and
computational chemistry, lipid identification remains a
significant challenge in lipidomics. Ion-mobility spectrometry
provides an accurate measure of the molecules’ rotationally
averaged collision cross-section (CCS) in the gas phase and is
thus related to ionic shape. Here, we investigate the use of
CCS as a highly specific molecular descriptor for identifying
lipids in biological samples. Using traveling wave ion mobility
mass spectrometry (MS), we measured the CCS values of over
200 lipids within multiple chemical classes. CCS values derived from ion mobility were not affected by instrument settings or
chromatographic conditions, and they were highly reproducible on instruments located in independent laboratories
(interlaboratory RSD < 3% for 98% of molecules). CCS values were used as additional molecular descriptors to identify
brain lipids using a variety of traditional lipidomic approaches. The addition of CCS improved the reproducibility of analysis in a
liquid chromatography-MS workflow and maximized the separation of isobaric species and the signal-to-noise ratio in direct-MS
analyses (e.g., “shotgun” lipidomics and MS imaging). These results indicate that adding CCS to databases and lipidomics
workflows increases the specificity and selectivity of analysis, thus improving the confidence in lipid identification compared to
traditional analytical approaches. The CCS/accurate-mass database described here is made publicly available.
Fueled by novel analytical technologies and a resurgentinterest in lipid biochemistry, lipidomics has become a
widely accepted analytical approach for biomarker discovery
and translational medicine.1−4 Alterations in lipid metabolism
have been associated with various human diseases, including
metabolic syndrome and Alzheimer’s disease.2,5,6 Recently,
lipidomic studies based on mass spectrometric analysis have
identified, characterized, and quantified almost 600 lipid
molecular species in human plasma.7 It is predicted, however,
that thousands of currently unknown lipids exist in biological
samples.2,7,8 To partially address this problem, MS and MS/MS
lipid databases have been developed using both reference
standards and in silico methods.8−13 Yet because of the variety
and complexity inherent in lipid structures, MS-based lipid
identification remains the most challenging step in a lipidomic
workflow.
Historically, chromatographic separation has been used to
maximize lipid separation prior to MS detection. More recently,
a gas-phase separation tool such as traveling-wave ion mobility
(TWIM) has been used in combination with MS. The
combined approach facilitates lipid analysis14 by increasing
peak capacity,15,16 improving structural elucidation,17−19 and
separating isomeric species.15,20−23 In TWIM-MS, an ion-
mobility separation stage consisting of a stacked-ring ion guide
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with RF confinement is filled with an inert gas such as nitrogen.
Ions travel through the gas toward the MS detector propelled in
an axial direction by a traveling-wave, DC voltage.24 Ions are
thus separated in the gas phase according to their mobility
through the gas, which is related to the ions’ charge, shape, and
size.
The time required for an ion to transverse the ion-mobility
separation cell is called drift time. From the drift time values, it
is possible to derive the rotationally averaged collision cross
section (CCS), which represents the effective area for the
interaction between an individual ion and the neutral gas
through which it is traveling.25−28 Thus, in addition to accurate
mass data, ion mobility-derived CCS provides an additional
physicochemical measurement that can be used for lipid
annotation and identification.
In this multilaboratory study, we investigated the use of ion
mobility-derived CCS as an additional molecular descriptor for
lipid identification using a variety of traditional lipidomics
approaches. In addition, we generated a publicly available
database, containing CCS and accurate-mass values, to support
lipid identification.
■ MATERIAL AND METHODS
All chemicals were purchased from Sigma-Aldrich (Seelze,
Germany) and were of analytical grade, or higher, purity. Fatty
acids were purchased from Cayman Chem (Ann Arbor,
Michigan USA) and Nu-Chek (Elysian, Minnesota USA).
The remaining lipid standards were all purchased from Avanti
Polar Lipids (Alabaster, Alabama USA), including 1-stearoyl-2-
arachidonoyl-sn-glycero-3-phosphocholine, 1,2-dioleoyl-sn-glyc-
ero-3-phosphocholine, 1-stearoyl-2-docosahexaenoyl-sn-glyc-
ero-3-phosphoethanolamine, ceramides, cholesterol, natural
lipid classes purified from animal tissues, and total lipid extracts
from porcine brain, E. coli, and yeast (See Table S1 in the
Supporting Information for additional information). Frozen
human brain samples (frontal cortex; age = 75.5 ± 5.0 years;
average, post-mortem interval = 3.2 ± 0.4 h; n = 6 ± SD) were
obtained from the Banner Sun Health Research Institute (Sun
City, Arizona USA). All subjects or their caregivers, where
applicable, provided written, informed consent for the clinical
examination as well as for brain donation at the Banner Sun
Health Research Institute Brain and Body Donation Program.
The protocols and informed consent have been approved by
the Banner Health Institutional Review Board.
Lipid Extractions. Frozen brain samples were rapidly
weighed and homogenized in ice-cold methanol (1 v). Lipids
were extracted by adding chloroform (2 v) and water (1 v) and
centrifuged at 10 000g for 10 min at 4 °C. The bottom phases
were dried under nitrogen, reconstituted in isopropanol/
acetonitrile/water (4:3:1, v/v/v; 0.1 mL), and subjected to
further analysis.
CCS Measurements. Traveling wave ion mobility mass
spectrometers (Synapt G2 HDMS, Waters, Corporation,
Manchester, UK), located in different laboratories, were used
to derive CCS values for various lipid classes. A mass range of
m/z 50−1500, with the mass spectrometer operating in both
positive and negative electrospray ionization, was used. A
summary of the MS settings appears in Table S2 (Supporting
Information). Direct injection at 5 μL/min was used. CCS
values, obtained in nitrogen, were experimentally determined
using previously published CCS values for singly charged
polyalanine oligomers as the TWIM calibrant species in both
ESI+ and ESI− mode26,27 (Table S3 in the Supporting
Information). Poly-DL-alanine was prepared in 50:50 (v/v)
water/acetonitrile at a concentration of 10 mg/L. Calibration
was performed using singly charged oligomers from n = 3 to n
= 14. The calibration encompassed a mass range extending
from 231 to 1012 Da and a CCS range extending from 151 Å2
to 306 Å2, in ESI+, and from 150 Å2 to 308 Å2, in ESI− (Table
S3 in the Supporting Information).26 CCS values were derived
according to previously reported procedures.26,28 The ion-
mobility resolution was ∼40 Ω/ΔΩ(fwhm). The ion-mobility
peak, or arrival-time distribution (ATD), may represent a
combination of structurally similar isomers that remain
unresolved. The CCS values reported were determined at the
apex of the ATD.29
UHPLC-TWIM-MS Lipidomic Analysis. Lipidomic anal-
yses of brain samples were performed with a microfluidics
ionKey/MS system composed of an ACQUITY UPLC M-
Class, the ionKey source, and an iKey CSH C18 130 Å, 1.7 μm
particle size, 150 μm × 100 mm column (Waters Corporation,
Milford, Massachusetts, USA) coupled to a Synapt G2-Si
(Waters Corporation, Manchester, UK). Analyses were
conducted in both positive and negative electrospray mode.
The capillary voltage was 2.8 kV and the source temperature
110 °C. Injections were 0.5 μL using partial-loop mode, with a
column temperature of 55 °C and flow rate of 3 μL/min.
Mobile phase A consisted of acetonitrile/water (60:40) with 10
mM ammonium formate +0.1% formic acid. Mobile phase B
consisted of isopropanol/acetonitrile (90:10) with 10 mM
ammonium formate +0.1% formic acid. The gradient was
programmed as follows: 0.0−2.0 min from 40% B to 43% B,
2.0−2.1 min to 50% B, 2.1−12.0 min to 99% B, 12.0−12.1 min
to 40% B, and 12.1−14.0 min at 40% B.
TWIM-MS Tissue Imaging. Frozen, human, brain samples
were serially sectioned in a cryostat, to allow alternate
microscopic and MS-imaging analyses. Sections were placed
on standard microscope slides and kept frozen at −15 °C
throughout the analysis using the Peltier cooled stage of the
Laser Ablation Electrospray Ionization (LAESI) DP-1000.
Sections were analyzed using the LAESI DP-1000 Direct
Ionization System (Protea Bioscience, Morgantown, West
Virginia, USA) coupled with a Synapt G2-S mass spectrometer
(Waters Corporation, Manchester, UK). The electrospray
solution for LAESI was methanol/water (50:50, v/v) with
0.1% acetic acid. LAESI-TWIM-MS parameters consisted of 10
laser pulses per pixel at 5 Hz and 800 uJ of laser energy. Data
were collected in both negative- and positive-ion mode using a
mass range of m/z 50 to 1500 for MS scans as well as for ion-
mobility-MS scans. Identifications were made according to
accurate-mass and CCS values. Selected drift-time regions were
extracted using Driftscope (Waters Corporation, Manchester,
U.K.). Ion distribution maps were created for mass values of
interest using ProteaPlot v2.0.3.8 (Protea Bioscience, Morgan-
town, West Virginia, USA).
Data Processing and Analysis. Data processing,
quantitative analysis, and database searches were conducted
using Progenesis QI Informatics (Nonlinear Dynamics, New-
castle, U.K.). Each UHPLC-TWIM-MS run was imported as an
ion-intensity map including m/z and retention time. The
software automatically converted drift time data to CCS values
using the polyalanine calibration. Lipids were identified by
searching publicly available databases (i.e., Human Metabolome
Database (HMDB),11 METLIN,12 and LipidsMaps8) and in-
house databases containing masses, retention times, fragment
information, and ion mobility-derived CCS values.
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■ RESULTS AND DISCUSSION
We recently reported the first CCS database for polar
metabolites, showing its applicability and utility in supporting
metabolomics experiments.28 In the present study, we extended
our previous investigation by implementing ion mobility-
derived CCS in routine lipidomics workflows. In a multi-
laboratory effort, we calculated CCS values of an array of
common lipid classes (Figure 1), generating a searchable
database containing CCS and accurate-mass values (Tables S4
and S5 in Supporting Information). This database was then
used as an aid in identifying lipids from brain samples.
Ion Mobility-Derived CCS Values for Lipids. To
implement the use of ion mobility in routine MS-based
lipidomics workflows, we measured the CCS of the most
common lipid classes in independent laboratories (Figure 2a,b).
We obtained CCS values for 244 lipids representing 13 lipid
classes (101 values in positive ion mode and 143 values in
negative ion mode; Tables S4 and S5 in the Supporting
Information) with an inter-laboratory RSD lower than 3% for
98% of the measurements (Figure 2c,d). These results highlight
the fact that, as previously reported for polar metabolites,28
CCS values of lipids are highly reproducible, independently of
the particular experimental conditions employed (Table S2 in
Figure 1. Lipid classes analyzed in this study. Categorization of lipids based upon their chemical structures. Highlighted in red are the core-structures
from which the various lipid classes take their name. Highlighted in blue are the functional groups from which the various lipid subclasses take their
name. Abbreviations: PC, phosphatidylcholine; PE, phosphatidylethanolamine; PS, phosphatidylserine; PG, phosphatidylglycerol; PI,
phosphatidylinositol; Cer, ceramide; SM, sphingomyelin; HexCer, hexosyl ceramide; Cho, cholesterol.
Figure 2. A CCS database for lipids. A total of 244 lipids were included in the CCS database. CCS values were obtained for different lipid classes and
subclasses in both positive ESI+ (a) and negative ESI− ionization (b). Frequency distribution plot of Relative Standard Deviations (RSD) obtained
for the CCS measurements of the lipid species across different laboratories in both positive (c) and negative (d) ionization mode.
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the Supporting Information). This reproducibility is the result
of the stability of the ion mobility technology as well as the use
of calibrants that correct for variation in the instruments’ drift
times.
To our knowledge, this is the first report providing CCS
values for lipid anions. The CCS values for the lipid cations
agree with those previously reported in the literature, deriving
both from standard tissue extracts measured with drift
tubes29,30 or standard lipids measured with TWIM-MS17,18
(Table S6 in the Supporting Information). Such evidence
indicates that power fit calibration of the TWIM-MS device
provides accurate and reliable CCS values in good agreement
with those obtained from drift tube studies.31
Ion mobility CCS measurements can, by inference, provide
information about the shape of lipid molecules. Extending what
has already been found in previous studies,14,18,32,33 CCS of
various lipid classes (e.g., phosphatidylcholines and sphingo-
myelins) and lipid subclasses (e.g., vinyl ether phosphatidyle-
thanolamines and acyl phosphatidylethanolamines) fell into
distinct trend lines on an m/z-versus-CCS chart, according to
their chemical structures (Figure 3a and b). To confirm lipid
identities, we relied on HDMSE acquisition mode, in which
precursor ions are fragmented in a collision cell after the TWIM
separation as previously reported.15,16,19,28 These results
suggest that CCS values provide an additional coordinate of
information for lipid identification and structure confirmation.
To test the accuracy and precision of the CCS measurements
in different matrices, we compared the CCS values in our
database with those derived from a range of lipid extracts
including porcine brain, E. coli and yeast (Figure S1 in the
Supporting Information). Our results show that CCS values for
the same lipids are conserved between different extracts,
indicating high reproducibility of CCS measurements in varying
matrices. These results also demonstrate the wide applicability
of our database across lipid extracts of various origins to
support lipid identification (Figure S1 in the Supporting
Information).
Lipid identification is a critical step for converting data into
meaningful biological results.8,11,12,34,35 In a typical MS-based
lipidomic experiment, features of interest are usually searched
against databases that list physicochemical properties descrip-
tive of each lipid (e.g., accurate mass). A minimum of at least
Figure 3. Mass versus CCS correlation curves for various lipid classes. (a) Lipids classes were grouped on the basis of their m/z and CCS values. (b)
Representative separation of the lipid subclasses phosphatidylethanolamine (PE, green dots) and plasmalogen PE (PEp, blue squares), which were
tentatively identified.
Figure 4. Intra-lab reproducibility and specificity of analysis by separation method. The half height widths for each of the three measured
distributions (m/z, retention time and drift time) for the human brain lipidome across six samples, showing higher reproducibility of drift time
measurements compared to retention time values.
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two physicochemical measures are required for confident lipid
identification.36 In this context, a TWIM-MS experiment
provides two measurements for lipids identification (i.e.,
accurate mass and CCS measurements) in a single acquisition.
By annotating the accurate-mass and CCS values for each
species, we created a unique database of common lipids
available as a resource to the wider IM-MS community (Tables
S4 and S5, in the Supporting Information).
A UHPLC-MS Lipidomic Workflow That Exploits CCS
Information. To exploit the use of ion-mobility-derived CCS
information in a typical lipidomic experiment, we analyzed
human brain samples by microscale UHPLC/TWIM-MS using
an integrated microfluidic device. The goal of this experiment
was to improve the confidence in lipid identification from
biological samples using CCS as an additional coordinate of
information.
An in-depth analysis of the UHPLC/TWIM-MS data
revealed that each brain sample contained more than 25 000
detectable ions. Each ion was associated with characteristic m/z,
retention time, and CCS values. Ions consistently present in all
samples were matched according to m/z < 10 ppm, retention
time <6 s, and drift time <1 bin, resulting in 5151 detectable
ions found in all six experiments. The mean intralaboratory
analytical precision was RSD ∼0.2% for CCS values, compared
with RSD ∼ 0.5% for retention-time values, which is in
agreement with a previous report showing that CCS measure-
ments are more stable and reliable than retention-time values
(Figure 4).28 Our results indicate that CCS, because of its
stability and reproducibility, increases the degrees of freedom in
matching ions between data sets, improving the accuracy and
precision of both qualitative and quantitative measurements for
lipidomics analysis.
To identify the ions, we first performed isotope and adduct
deconvolution. We then searched their accurate masses against
publicly available databases, including LipidMaps,8 HMDB,11
and Metlin.12 This process disclosed more than 1300 putative
candidate identifications. Next, we cross-searched those
potential identifications against our CCS lipid database,
applying ΔCCS <3% as the difference between reference
CCS values in our database and the experimental CCS values.
The combination of CCS and accurate mass increased the
confidence of identification for 137 lipids (red dots in Figure S2
in the Supporting Information). Such results indicate that
applying CCS information can reduce the complexity of
UHPLC-MS lipidomic results, facilitating rapid and reliable
data interpretation.
Direct Analysis-MS Lipidomics Using CCS Informa-
tion. Lipid databases containing CCS values may be of
particular significance for interpreting direct-infusion MS
“shotgun” lipidomicsor desorption ionization-MS (e.g., MS
imaging) lipidomic experiments. Such interpretations usually
rely exclusively on one physicochemical measurement (i.e.,
accurate mass) for lipid fingerprinting and identification.37−41
To test this hypothesis, we exploited CCS information in
typical shotgun lipidomics and MS-imaging experiments.
CCS to Support Direct-Infusion, or Shotgun, Lipidomics.
Commonly referred to as “shotgun” lipidomics, direct infusion
of lipid extracts into a mass spectrometer without prior
chromatographic separation provides an approach for high-
throughput lipidomics.42 Yet the approach suffers from a
Figure 5. CCS in support of shotgun lipidomics. (a) Lipid extracts from porcine brain were directly infused in the TWIM-MS in positive ESI mode.
Lipids were separated into two dimensions according to both CCS and m/z. The additional CCS coordinate allowed separation and identification of
near isobaric lipids, including SM d18:1/18:0 at m/z 731.6097 and PC 40:6 at m/z 834.6021, increasing the specificity of analysis. (b) At 35 000
mass resolution, about 15% of the total 5639 ions were independently measured. The addition of CCS allowed independent measurment of about
85% of the total ions, increasing peak capacity.
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reduced ability to distinguish isobaric and isomeric species in
crude lipid extracts.14,29,43
To evaluate the applicability of CCS information to a
shotgun lipidomic analysis, we infused commercially available
lipid extracts from porcine brain samples directly into the ESI-
TWIM mass spectrometer, in positive ionization mode (5 μL/
min per 1 min).14,29,43 A 30 s slice of the infusion was
processed with the detection algorithm Apex3D utilizing a fixed
chromatographic peak width of 30 s.44 Lipids were separated in
two dimensions, according to CCS and m/z (Figure 5a). The
additional dimension of ion-mobility separation increased the
peak capacity of a traditional direct-infusion MS experiment
more than 5-fold (Figure 5b), agreeing with previous
reports.32,45 Without CCS, at a mass resolution of 35 000
(fwhm), we were able to measure 860 independent ions, 15%
of the 5639 total ions counted (Figure 5b). Thus, the addition
of CCS allowed the resolution of 3911 additional ions (Figure
5b). The observed increase in peak capacity of analysis
ultimately allows separation of isobaric species improving
lipid fingerprinting and quantification in shotgun lipidomics
applications.
We further examined the brain data set using our CCS lipid
database to evaluate the use of mass accuracy alone versus
combining CCS with mass accuracy for identification. A cutoff
of 10 ppm and CCS ± 2% in our database search criteria
allowed us to identify, with high confidence, 34 brain-lipid
species, including SM d18:1/18:0 and PC 40:6 (Figure 5a;
Tables S7 and S8 in the Supporting Information). Applying a
cutoff of 10 ppm without any CCS filter, we found 21
mismatched lipid identifications (false positives), compared
with the results obtained using 10 ppm and CCS as filters
(Tables S7 and S8 in the Supporting Information).
Furthermore, applying a cutoff of 5 ppm without CCS, we
found nine mismatches and 13 missed matches (false
negatives), compared with the results obtained using 10 ppm
and CCS as filters (Tables S7 and S8 in the Supporting
Information). These results indicate that CCS allows for
applying an additional set of tolerance criteria to shotgun
lipidomics experiments, which might result in a reduced
number of false-negative and false-positive identifications,
ultimately leading to more confident compound identification.
CCS to Support MS Imaging. MS imaging provides the
detailed spatial distribution of lipid species on biological tissues.
Lipids are prominent features in MS imaging spectra of
biological tissues under most desorption ionization sources,
including matrix-assisted laser desorption ionization
(MALDI)16,46,47 and desorption electrospray ionization
(DESI).48,49 Two significant challenges in MS imaging
experiments are (i) accurate lipid localization, which may be
affected by the presence of confounding isobaric species,41 and
(ii) lipid identification, which relies, mostly, on accurate mass,
because of the impractical nature of conducting a large number
of MS/MS experiments on a single tissue section.37,40,50
To exploit the use of CCS information to improve MS-
imaging applications, we analyzed human brain samples using
LAESI coupled to a TWIM-MS instrument. Using CCS
information allowed us to isolate lipids from metabolites,
multiply charged proteins, and peptides, and from the
background ions associated with atmospheric ionization
(Figure 6a−c). Identities of 93 lipid species were confirmed
by means of both accurate-mass and CCS measurements.
Topographical maps representing the lipid ion distribution in
subregions of the human brain were created for selected mass
and CCS values present in gray matter (Figure 6d) and white
matter (Figure 6e). The use of ion mobility allowed the spatial
separation of isobaric lipid species with different CCS values,
improving the quality of the signal-to-noise ratio (Figure 6f,g).
Notably, only by using this approach was it possible to
determine the selective spatial localization of PC 34:2 in the
gray matter versus ceramide C24:1 in white matter. These
Figure 6. CCS in support of MS imaging. Identification and spatial localization of selected lipid species in human brain sections using LAESI-TWIM-
MS. (a) Desorption ionization of human brain samples generated complex spectra composed of metabolites, lipids, and proteins that were separated
in a bidimensional plot by both m/z and ion mobility. Red arrows denote two lipid species, Ceramide C24:1 (Cer C24:1) and PC 34:2, overlapping
in the m/z dimension with near isobaric species but having different drift times. Close-up of drift regions for Cer C24:1 (b) and for PC 34:2 (c). (d)
MS imaging of human brain showed a marked localization in the gray matter for the extracted ion at m/z 758.5977 (4.7 ppm) and CCS 294.1 Å2
(ΔCCS< 1%) corresponding to PC 34:2 [M + H]+; (e) MS imaging of human brain depicted a selected localization in the white matter for the
extracted ion at m/z 630.6193 (−1.5 ppm) and CCS 282.5 Å2 (ΔCCS< 1%) corresponding to Cer C24:1, [M-H2O+H]+; MS imaging of human
brain generated using m/z values, without CCS selection, for PC 34:2 (f) and Cer C24:1 (g) showed low specificity and low signal-to-noise, which
ultimately affected spatial resolution.
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results indicate that CCS information may be a significant tool
supporting lipid identification and localization in MS imaging
studies.
■ CONCLUSIONS
In this study, we implemented the use of ion mobility-derived
CCS measurements in lipidomics workflows to improve the
specificity of data analysis and to facilitate lipid identification.
We measured CCS values for over 200 common lipids in both
positive- and negative-ion mode across independent laborato-
ries. The measurements showed high reproducibility, and they
were uninfluenced by instrument settings and chromatographic
conditions. We annotated these CCS values in a unique lipid
database, now available to everyone. When added to a liquid
chromatography-MS-based lipidomics workflow, CCS data
improved the reproducibility of analysis. When added to
direct-MS lipidomics approaches (e.g., “shotgun” lipidomics
and MS imaging), CCS measurements maximized the
separation of isobaric species and increased the signal-to-
noise ratio. Overall, our study demonstrates that the addition of
CCS in databases and lipidomic workflows improves the
accuracy and precision of analysis and thus the confidence in
lipid assignment compared to traditional analytical approaches.
We encourage further studies to extend and populate existing
lipid databases with CCS values for lipid applications.
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